A CNN poll this month indicated 40% of Americans wouldn’t get a Covid-19 vaccine, even if it’s free and easy to access.
Part of the problem is public skepticism of the FDA after the agency’s premature authorization of
hydroxychloroquine and convalescent plasma therapy, said Dr. Rochelle Walensky, chief of infectious diseases at Massachusetts General Hospital.
Both hydroxychloroquine and convalescent plasma therapy have been touted by President Donald Trump, who appointed the FDA commissioner.
“The problem is both with hydroxychloroquine and with the convalescent plasma, we saw a real politicization of that scientific debate in a way that I think has all of us concerned,” Jha said.